The RAISE Study: Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer
Summary
The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP(E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYA with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.
Arms & interventions
- BehavioralPsychosocial Intervention for Parental Caregivers of AYA with Cancer
A new adaptation of an evidence-supported intervention, the SMART-3RP program, to address psychological symptoms and promote well-being among parental caregivers of AYA with cancer.
Outcome measures
Primary
Intervention Feasibility: Percent of Identified Prospective Participants Who Enroll
Percent of eligible participants who were offered participation and who enroll in the study by completing consent and baseline assessment.
Time frame: Post-treatment completion (enrollment to treatment completion is approximately 3 months)
Intervention Feasibility: Proportion of Participants Completing the Program
Percent of enrolled participants who complete the program, defined as completing 6 out of 8 sessions.
Time frame: Post-treatment completion (enrollment to treatment completion is approximately 3 months)
Intervention Acceptability
Acceptability will be assessed by the Client Satisfaction Questionnaire (CSQ-8). The intervention study will be considered acceptable if ≥80% of participants rate it as acceptable (defined as a CSQ-8 score ≥20).
Time frame: Post-treatment completion (enrollment to treatment completion is approximately 3 months)
Eligibility criteria
Study locations (1)
Mass General Brigham Cancer Institute at Massachusetts General Hospital
Boston, Massachusetts, 02114